Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-05-09 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program' announced previously. This action directly relates to the company trading its own stock, which corresponds to the 'Transaction in Own Shares' category. The short length and reference to reading the 'full announcement in PDF' suggest it might be a brief notification, but the core content is the transaction itself, making POS the most specific fit over RPA or RNS.
2016-05-09 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made by Novozymes under its stock buyback program, including the number of shares purchased, average price, and total transaction value over specific dates (May 2 to May 6, 2016). This directly relates to the company managing its own shares. The category 'Transaction in Own Shares (Code: POS)' is defined as the 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The content perfectly matches this definition, as it is a report detailing the execution of a share repurchase program.
2016-05-09 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement detailing specific transactions related to Novozymes' share buyback program (aktietilbagekøbsprogram). It provides a table of daily share purchases, the accumulated total, and the impact on the company's treasury shares. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2016-05-09 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 92% confidence The document announces Novozymes’ purchase of its own shares under an ongoing share buy-back program, including number of shares and transaction value. This is a share repurchase notice, fitting the “Transaction in Own Shares” category.
2016-05-09 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program' conducted by Novozymes, including the number of shares purchased, the transaction value, and specific dates (April 25 to April 29, 2016). This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (3048 chars), but it is a detailed report of the transactions, not an announcement of a report's publication.
2016-05-02 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text is very short (253 characters) and explicitly states that Novozymes bought back shares under a previously announced share repurchase program. It concludes with 'Læs hele meddelelsen i PDF' (Read the full announcement in PDF). This structure—a brief summary of a transaction followed by a pointer to the full document—strongly suggests this is an announcement about a transaction in own shares, fitting the 'Transaction in Own Shares' category (POS). It is not the full report itself, but a notification of the activity.
2016-05-02 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.